Raras
Buscar doenças, sintomas, genes...
Displasia tanatofórica
ORPHA:2655CID-10 · Q77.1CID-11 · LD24.02DOENÇA RARA

É uma doença primária dos ossos que causa braços e pernas curtos, e se manifesta com cabeça maior que o normal, tórax estreito e características faciais peculiares. Existem dois tipos: TD tipo 1 (TD1) e TD tipo 2 (TD2), que podem ser diferenciados pelo formato do fêmur (o osso da coxa) e do crânio (o osso da cabeça).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É uma doença primária dos ossos que causa braços e pernas curtos, e se manifesta com cabeça maior que o normal, tórax estreito e características faciais peculiares. Existem dois tipos: TD tipo 1 (TD1) e TD tipo 2 (TD2), que podem ser diferenciados pelo formato do fêmur (o osso da coxa) e do crânio (o osso da cabeça).

Publicações científicas
442 artigos
Último publicado: 2026 Feb

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
Antenatal
+ neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q77.1
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
17 sintomas
🧠
Neurológico
10 sintomas
😀
Face
5 sintomas
🫁
Pulmão
4 sintomas
❤️
Coração
3 sintomas
🧬
Pele e cabelo
2 sintomas

+ 34 sintomas em outras categorias

Características mais comuns

90%prev.
Hipoplasia pulmonar
Muito frequente (99-80%)
90%prev.
Displasia esquelética
Muito frequente (99-80%)
90%prev.
Deficiência intelectual, profunda
Muito frequente (99-80%)
90%prev.
Face plana
Muito frequente (99-80%)
90%prev.
Pele redundante
Muito frequente (99-80%)
90%prev.
Macrocefalia
Muito frequente (99-80%)
84sintomas
Muito frequente (15)
Frequente (8)
Ocasional (18)
Sem dados (43)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 84 características clínicas mais associadas, ordenadas por frequência.

Hipoplasia pulmonarPulmonary hypoplasia
Muito frequente (99-80%)90%
Displasia esqueléticaSkeletal dysplasia
Muito frequente (99-80%)90%
Deficiência intelectual, profundaIntellectual disability, profound
Muito frequente (99-80%)90%
Face planaFlat face
Muito frequente (99-80%)90%
Pele redundanteRedundant skin
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico442PubMed
Últimos 10 anos110publicações
Pico201814 papers
Linha do tempo
2026Hoje · 2026🧪 2015Primeiro ensaio clínico📈 2018Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant, Not applicable.

FGFR3Fibroblast growth factor receptor 3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation and apoptosis. Plays an essential role in the regulation of chondrocyte differentiation, proliferation and apoptosis, and is required for normal skeleton development. Regulates both osteogenesis and postnatal bone mineralization by osteoblasts. Promotes apoptosis in chondrocytes, but can also promote cancer cell proliferat

LOCALIZAÇÃO

Cell membraneCytoplasmic vesicleEndoplasmic reticulumSecreted

VIAS BIOLÓGICAS (2)
Signaling by FGFR3 in diseaset(4;14) translocations of FGFR3
MECANISMO DE DOENÇA

Achondroplasia

A frequent form of short-limb dwarfism. It is characterized by a long, narrow trunk, short extremities, particularly in the proximal (rhizomelic) segments, a large head with frontal bossing, hypoplasia of the midface and a trident configuration of the hands. ACH is an autosomal dominant disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
364.6 TPM
Skin Sun Exposed Lower leg
356.5 TPM
Esôfago - Mucosa
199.7 TPM
Brain Caudate basal ganglia
148.4 TPM
Brain Nucleus accumbens basal ganglia
135.4 TPM
OUTRAS DOENÇAS (19)
nevus, epidermalsevere achondroplasia-developmental delay-acanthosis nigricans syndromelacrimoauriculodentodigital syndrome 2testicular germ cell tumor
HGNC:3690UniProt:P22607

Variantes genéticas (ClinVar)

416 variantes patogênicas registradas no ClinVar.

🧬 FGFR3: GRCh38/hg38 4p16.3-15.33(chr4:68454-12774004)x1 ()
🧬 FGFR3: GRCh38/hg38 4p16.3(chr4:68454-4013853)x3 ()
🧬 FGFR3: NM_000142.5(FGFR3):c.2173A>G (p.Met725Val) ()
🧬 FGFR3: NM_000142.5(FGFR3):c.380-1G>A ()
🧬 FGFR3: GRCh38/hg38 4p16.3(chr4:49556-3910769)x1 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 46 variantes classificadas pelo ClinVar.

14
30
2
Patogênica (30.4%)
VUS (65.2%)
Benigna (4.3%)
VARIANTES MAIS SIGNIFICATIVAS
FGFR3: NM_000142.5(FGFR3):c.1827C>G (p.Ala609=) [Conflicting classifications of pathogenicity]
FGFR3: NM_000142.5(FGFR3):c.1954A>G (p.Thr652Ala) [Pathogenic]
FGFR3: NM_000142.5(FGFR3):c.2420G>C (p.Ter807Ser) [Pathogenic]
FGFR3: NM_000142.5(FGFR3):c.2005C>G (p.Arg669Gly) [Conflicting classifications of pathogenicity]
FGFR3: NM_000142.5(FGFR3):c.200G>A (p.Gly67Asp) [Conflicting classifications of pathogenicity]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Displasia tanatofórica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
103 papers (10 anos)
#1

Type I Thanatophoric Dysplasia: Clinical Outcome in the Absence of Molecular Genetic Confirmation: A Case Report.

Cureus2026 Feb

Thanatophoric dysplasia (TD) is the most common lethal congenital skeletal dysplasia, characterized by severe micromelia, a narrow thorax, and frontal bossing due to activating mutations in the fibroblast growth factor receptor 3 (FGFR3) gene on chromosome 4p16.3. First described by Maroteaux and Lamy in 1967, it carries a near-uniform perinatal mortality from respiratory insufficiency. We present the case of a male newborn in whom the diagnosis of thanatophoric dysplasia was established during the antenatal period.

#2

The Clinical Utility of Whole-Exome Sequencing in the Prenatal Diagnosis of Fetal Skeletal Dysplasia.

International journal of women's health2026

To investigate the clinical application value of exome sequencing technology in fetuses with sonographically detected skeletal dysplasia. A total of 80 pregnant women whose fetuses were diagnosed with sonographically detected skeletal dysplasia at 11⁺0 to 38⁺0 weeks of gestation in our hospital from March 2021 to January 2022 were enrolled in this study. G-banded chromosomal karyotype analysis (KA), chromosomal microarray analysis (CMA) and whole exome sequencing (WES) were simultaneously performed for all cases. Clinical data including maternal age, gestational week, prenatal ultrasound findings, results of KA, CMA and WES, and pregnancy outcomes were collected and subjected to statistical analysis. Limb shortening was the most common phenotypic manifestation of fetal skeletal dysplasia. The diagnostic yield of KA combined with CMA for fetal skeletal dysplasia was only 7.5% (6/80), while the additional combination with WES identified 43 positive cases, with an overall diagnostic yield of 53.75% (43/80). There was a statistically significant difference in the diagnostic yield between the two detection protocols (χ2=50.19, P<0.001), with an absolute increase of 46.25% in the diagnostic yield after the integration of WES. The most common clinical disorders caused by pathogenic genes included osteogenesis imperfecta, achondroplasia and thanatophoric dysplasia. The majority of pathogenic variants were de novo mutations, mainly involving the COL1A1, FGFR2 and FGFR3 genes. Among the 43 WES-positive cases, 34 pregnancies opted for termination of pregnancy. Whole-exome sequencing technology holds important application value in the prenatal diagnosis of fetal skeletal system diseases, and provides a more accurate evidence base for genetic counseling and clinical decision-making.

#3

[Clinical features and variant spectrum of FGFR3-related disorders].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2025 Oct 15

To study genotype-phenotype correlations in children with FGFR3 variants and to improve clinical recognition of related disorders. Clinical data of 95 patients aged 0-18 years harboring FGFR3 variants, confirmed by whole‑exome sequencing at Shanghai Children's Medical Center from January 2012 to December 2023, were retrospectively reviewed. Detailed phenotypic characterization was performed for 22 patients with achondroplasia (ACH) and 10 with hypochondroplasia (HCH). Among the 95 patients, 52 (55%) had ACH, 24 (25%) had HCH, 9 (9%) had thanatophoric dysplasia, 3 (3%) had syndromic skeletal dysplasia, 2 (2%) had severe achondroplasia with developmental delay and acanthosis nigricans, and 5 (5%) remained unclassified. A previously unreported FGFR3 variant, c.1663G>T, was identified. All 22 ACH patients presented with disproportionate short stature accompanied by limb dysplasia, commonly with macrocephaly, a depressed nasal bridge, bowed legs, and frontal bossing; complications were present in 17 (77%). The 10 HCH patients predominantly exhibited disproportionate short stature with limb dysplasia and depressed nasal bridge. ACH is the most frequent phenotype associated with FGFR3 variants, and missense variants constitute the predominant variant type. The degree of FGFR3 activation appears to correlate with the clinical severity of skeletal dysplasia. 目的: 分析FGFR3基因变异患儿的基因型-表型特点,提高临床医生对相关疾病的认识。方法: 回顾性分析2012年1月—2023年12月在上海儿童医学中心经全外显子组测序确诊的95例0~18岁FGFR3基因变异患儿的临床资料,其中22例软骨发育不全(achondroplasia, ACH)患儿和10例软骨发育不良(hypochondroplasia, HCH)患儿纳入后续表型分析。结果: 95例患儿中,52例(55%)为ACH,24例(25%)为HCH,9例(9%)为致死性侏儒症,3例(3%)为综合征型骨骼异常,2例(2%)为严重软骨发育不全伴发育迟缓和黑棘皮病,5例(5%)诊断待明确。c.1663G>T为新发现变异位点。22例ACH患儿均表现为非匀称性矮小伴肢体发育不良,常伴大头畸形、鼻梁凹陷、弓形腿和前额突出,其中17例(77%)合并并发症。10例HCH患儿主要表现为非匀称性矮小、肢体发育不良和鼻梁凹陷。结论: ACH是FGFR3基因变异最常见的疾病类型,错义变异是其主要变异形式。受体活化程度的强弱与骨骼发育异常临床表型的严重程度有关。.

#4

Thanatophoric Dysplasia Type 1 Treated with Vosoritide: A Case Report.

Hormone research in paediatrics2025 Oct 10

Thanatophoric dysplasia type 1 (TD1) is the most severe form of FGFR3-related skeletal dysplasia, with high perinatal mortality and no approved pharmacologic therapies. Vosoritide, a C-type natriuretic peptide analogue that counteracts FGFR3 overactivation, improves growth in achondroplasia, but its effects in TD1 remain unexplored. We report the response to vosoritide therapy in a 9-year-old girl with genetically confirmed TD1 (c.2420G>T). Vosoritide was initiated at a dose of 15 µg/kg/day subcutaneously and increased to 30 µg/kg/day after 16 months. Growth velocity, anthropometry, pulmonary function, densitometry, and safety were assessed longitudinally over 28 months. At baseline, height was 78.6 cm (-10.9 SDS) and annual growth velocity (AGV) 1.6 cm/year (-4.7 SDS). After 28 months, height increased by +1.3 SDS and AGV by +2.0 cm/year (+3 SDS from baseline). Lung vital capacity improved by 65%. Serial MRI demonstrated persistent severe foramen magnum stenosis without radiological progression. Adverse events were limited to transient injection-site reactions and mild vasovagal episodes; no major safety concerns emerged. Vosoritide was well tolerated and improved growth velocity and lung function in this long-term TD1 survivor, suggesting therapeutic potential even in severe FGFR3 overactivation. Given TD1's rarity, larger studies and further off-label experience are essential to validate these findings.

#5

An immunohistochemical study of thanatophoric dysplasia type 1 after fetus autopsy examination.

Congenital anomalies2025

The current case report presents the postmortem examination findings of a 17-week-old female fetus displaying thanatophoric dysplasia type 1 (TD-1) due to a known fibroblast growth factor receptor 3 (FGFR3) gene mutation. Gross and X-ray examination revealed significant abnormalities, including skeletal malformations with prominent TD-1 femur curvature. Microscopical evaluation indicated inadequate histological growth for the gestational age, with specific organ immaturity noted in multiple hematoxylin and eosin sections from internal organs, bone from epiphyses and diaphyses levels. Immunohistochemical analysis was conducted using specific markers, such as S100, CD34, CD117, glycophorin-C, and myeloperoxidase, to identify various hematopoietic and mesenchymal cell types. Furthermore, this report underscores the often-overlooked aspect of fetal hematopoiesis in cases diagnosed with TD-1, shedding light on the development of hematopoietic cells and their markers in various tissues, with a particular emphasis on the investigation of bone marrow foci in areas with incipient or no apparent ossification. Immunohistochemical identification of hematopoiesis also served as an indirect way to identify areas of incipient or abnormal ossification.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC224 artigos no totalmostrando 108

2026

Type I Thanatophoric Dysplasia: Clinical Outcome in the Absence of Molecular Genetic Confirmation: A Case Report.

Cureus
2026

The Clinical Utility of Whole-Exome Sequencing in the Prenatal Diagnosis of Fetal Skeletal Dysplasia.

International journal of women's health
2025

Thanatophoric dysplasia: A case report.

Medwave
2025

[Clinical features and variant spectrum of FGFR3-related disorders].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2025

Thanatophoric Dysplasia Type 1 Treated with Vosoritide: A Case Report.

Hormone research in paediatrics
2025

An immunohistochemical study of thanatophoric dysplasia type 1 after fetus autopsy examination.

Congenital anomalies
2024

Thanatophoric Dysplasia With Concurrent Hydroureteronephrosis: A Rare Case Report From Rural Southern India.

Cureus
2024

A Single Multiplex PCR and Single-Nucleotide Extension Assay for the Detection of Common Thanatophoric Dysplasia I and II Mutations.

The Journal of molecular diagnostics : JMD
2024

A case of long-term survival of SADDAN treated with growth hormone for marked short stature.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
2024

Laparoscopic herniorrhaphy for inguinal hernia with thanatophoric dysplasia: A case report.

Asian journal of endoscopic surgery
2024

Perinatal imaging findings of a fetus with Pfeiffer syndrome and a heterozygous c.1019A>G, p.Tyr340Cys (Y340C) mutation in FGFR2 presenting a cloverleaf skull, craniosynostosis and short limbs on prenatal ultrasound mimicking thanatophoric dysplasia type II.

Taiwanese journal of obstetrics &amp; gynecology
2024

Prenatal ultrasound findings and prenatal diagnosis of fetal skeletal dysplasia.

Journal of clinical ultrasound : JCU
2024

Exploring the Micro-Mosaic Landscape of FGFR3 Mutations in the Ageing Male Germline and Their Potential Implications in Meiotic Differentiation.

Genes
2023

De novo variants of dominant monogenic disorders in Vietnam detected by a noninvasive prenatal test: a case series.

Personalized medicine
2023

Diagnosis of thanatophoric dysplasia using clinical exome screening.

Ceska gynekologie
2023

Thanatophoric dysplasia in nonadherent to antenatal care in low middle income country: a rare case reports.

Annals of medicine and surgery (2012)
2023

Skeletal Dysplasia: A Case Report.

Diagnostics (Basel, Switzerland)
2024

Thanatophoric Dysplasia - Rare Fatal Skeletal Dysplasia Detected on Prenatal Ultrasound.

Journal of medical ultrasound
2023

Orthopaedic Manifestations of Thanatophoric Dwarfism: A Case Report.

JBJS case connector
2023

Skeletal dysplasias of the fetus and infant: comprehensive review and our experience over a 10-year period.

Ceskoslovenska patologie
2023

The respiratory elastance ratio in thanatophoric dysplasia: A case report.

Pediatrics international : official journal of the Japan Pediatric Society
2023

Exome sequencing in fetuses with short long bones detected by ultrasonography: A retrospective cohort study.

Frontiers in genetics
2022

Whole exome sequencing combined with dynamic ultrasound assessments for fetal skeletal dysplasias: 4 case reports.

Medicine
2023

Genetic examination for fetuses with increased nuchal translucency by exome sequencing.

The journal of obstetrics and gynaecology research
2022

Spontaneous Rupture of Unscarred Uterus in a Term Primagravida with Lethal Skeletal Dysplasia Fetus (Thanatophoric dysplasia). A Case Report and Review of the Literature.

International medical case reports journal
2022

Thanatophoric Dysplasia: A Report of 2 Cases with Antenatal Misdiagnosis.

Case reports in pediatrics
2023

Should we offer prenatal exome sequencing for intrauterine growth restriction or short long bones? A systematic review and meta-analysis.

American journal of obstetrics and gynecology
2022

Clinical management and emerging therapies of FGFR3-related skeletal dysplasia in childhood.

Annals of pediatric endocrinology &amp; metabolism
2022

Fetal autopsy for the diagnosis of skeletal dysplasia and comparison with prenatal ultrasound findings over a 16-year period.

Journal of perinatal medicine
2022

Collagen X Marker Levels are Decreased in Individuals with Achondroplasia.

Calcified tissue international
2021

Thanatophoric dysplasia type 1 with temporal lobe dysplasia: Report of a case along with differential diagnosis.

Indian journal of pathology &amp; microbiology
2021

High-Resolution Melting Analysis for Rapid Detection of Mutations in Patients with FGFR3-Related Skeletal Dysplasias.

Genetic testing and molecular biomarkers
2022

Development of individuals with thanatophoric dysplasia surviving beyond infancy.

Pediatrics international : official journal of the Japan Pediatric Society
2020

INITIAL EXPERIENCE WITH 3D-ULTRASOUND AS AN ADJUNCT TO 2DULTRASOUND IN FETAL ANOMALY DIAGNOSIS IN A NIGERIAN DIAGNOSTIC FACILITY.

Annals of Ibadan postgraduate medicine
2021

Fatal fetal abnormality Irish live-born survival-an observational study.

Journal of community genetics
2021

Lack of Catch-Up Growth with Growth Hormone Treatment in a Child Born Small for Gestational Age Leading to a Diagnosis of Noonan Syndrome with a Pathogenic PTPN11 Variant.

Case reports in endocrinology
2021

Lethal and life-limiting skeletal dysplasias: Selected prenatal issues.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University
2021

Prenatal Diagnosis of Skeletal Dysplasia and Review of the Literature.

Case reports in obstetrics and gynecology
2022

Fetal Trigonocephaly (Strawberry Skull) in Early Pregnancy.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
2021

Early prenatal presentation of the cartilage-hair hypoplasia / anauxetic dysplasia spectrum of disorders mimicking recurrent thanatophoric dysplasia.

European journal of medical genetics
2021

Achondroplasia-First Report from India of a Rare FGFR3 Gene Variant.

Laboratory medicine
2021

Typical achondroplasia secondary to a unique insertional variant of FGFR3 with in vitro demonstration of its effect on FGFR3 function.

American journal of medical genetics. Part A
2021

Simultaneous detection of fetal aneuploidy, de novo FGFR3 mutations and paternally derived β-thalassemia by a novel method of noninvasive prenatal testing.

Prenatal diagnosis
2021

Thanatophoric dysplasia: A brief neuropathological review.

Clinical neuropathology
2022

Fetal Skeletal Dysplasias: Radiologic-Pathologic Classification of 72 Cases.

Fetal and pediatric pathology
2020

Should We Stop Calling Thanatophoric Dysplasia a Lethal Condition? A Case Report of a Long-Term Survivor.

Palliative medicine reports
2020

Thanatophoric Skeletal Dysplasia: A Case Report.

JNMA; journal of the Nepal Medical Association
2020

Rapid prenatal diagnosis of skeletal dysplasia using medical trio exome sequencing: Benefit for prenatal counseling and pregnancy management.

Prenatal diagnosis
2020

Fetal magnetic resonance imaging of skeletal dysplasias.

Pediatric radiology
2019

Clinical features and molecular genetic analysis of thanatophoric dysplasia type I in a neonate with a de novo c.2419 T > C (p. Ter807Arg) (X807R) mutation in FGFR3.

Experimental and molecular pathology
2019

National survey of prevalence and prognosis of thanatophoric dysplasia in Japan.

Pediatrics international : official journal of the Japan Pediatric Society
2019

Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA.

Nature medicine
2019

Thanatophoric dysplasia type 1 with tectal plate dysplasia and aqueductal stenosis.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2019

Bone dysplasias in 1.6 million births in Argentina.

European journal of medical genetics
2019

A new biometric: In utero growth curves for metacarpal and phalangeal lengths reveal an embryonic patterning ratio.

Prenatal diagnosis
2018

Chylous Ascites in an Infant with Thanatophoric Dysplasia Type I with FGFR3 Mutation Surviving Five Months.

Fetal and pediatric pathology
2018

Survival and healthcare utilization of infants diagnosed with lethal congenital malformations.

Journal of perinatology : official journal of the California Perinatal Association
2019

Prenatal sonographic findings and prognosis of craniosynostosis diagnosed during the fetal and neonatal periods.

Congenital anomalies
2018

Proposal of patient-specific growth plate cartilage xenograft model for FGFR3 chondrodysplasia.

Osteoarthritis and cartilage
2018

Noninvasive prenatal test for FGFR3-related skeletal dysplasia based on next-generation sequencing and plasma cell-free DNA: Test performance analysis and feasibility exploration.

Prenatal diagnosis
2018

C-type natriuretic peptide analog treatment of craniosynostosis in a Crouzon syndrome mouse model.

PloS one
2018

Novel and Recurrent Mutations in the FGFR3 Gene and Double Heterozygosity Cases in a Cohort of Brazilian Patients with Skeletal Dysplasia.

Molecular syndromology
2019

Multiplex PCR in noninvasive prenatal diagnosis for FGFR3-related disorders.

Congenital anomalies
2018

Prenatal diagnosis of hydrancephaly and enlarged cerebellum and cisterna magna in a fetus with thanatophoric dysplasia type II and a review of prenatal diagnosis of brain anomalies associated with thanatophoric dysplasia.

Taiwanese journal of obstetrics &amp; gynecology
2018

Regulation of ciliary function by fibroblast growth factor signaling identifies FGFR3-related disorders achondroplasia and thanatophoric dysplasia as ciliopathies.

Human molecular genetics
2018

Pathophysiological analyses of leptomeningeal heterotopia using gyrencephalic mammals.

Human molecular genetics
2018

A Lesson in Balancing Education and Empathy.

JAMA pediatrics
2018

Mutant FGFR3 associated with SADDAN disease causes cytoskeleton disorganization through PLCγ1/Src-mediated paxillin hyperphosphorylation.

The international journal of biochemistry &amp; cell biology
2018

Expanding the Clinical Spectrum of Phenotypes Caused by Pathogenic Variants in PLOD2.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2018

Temporal Lobe Malformations in Achondroplasia: Expanding the Brain Imaging Phenotype Associated with FGFR3-Related Skeletal Dysplasias.

AJNR. American journal of neuroradiology
2018

Constitutively-active FGFR3 disrupts primary cilium length and IFT20 trafficking in various chondrocyte models of achondroplasia.

Human molecular genetics
2017

Imaging of Skeletal Disorders Caused by Fibroblast Growth Factor Receptor Gene Mutations.

Radiographics : a review publication of the Radiological Society of North America, Inc
2017

Identification and in silico characterization of p.G380R substitution in FGFR3, associated with achondroplasia in a non-consanguineous Pakistani family.

Diagnostic pathology
2017

Comparative X-ray morphometry of prenatal osteogenesis imperfecta type 2 and thanatophoric dysplasia: a contribution to prenatal differential diagnosis.

La Radiologia medica
2017

Can biparietal diameter-to-femur length ratio be a useful sonographic marker for screening thanatophoric dysplasia since the first trimester? A literature review of case reports and a retrospective study based on 10,293 routine fetal biometry measurements.

Taiwanese journal of obstetrics &amp; gynecology
2017

Perinatal imaging findings and molecular genetic analysis of thanatophoric dysplasia type 1 in a fetus with a c.2419T>G (p.Ter807Gly) (X807G) mutation in FGFR3.

Taiwanese journal of obstetrics &amp; gynecology
2017

Genetically confirmed thanatophoric dysplasia with fibroblast growth factor receptor 3 mutation.

Experimental and molecular pathology
2017

Ultrasound diagnosis of fetal thanatophoric skeletal dysplasia: Three cases report and a brief review.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban
2017

Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.

American journal of medical genetics. Part A
2017

Metacarpal Bone Plane Examination by Ultrasonography for the Diagnosis of Fetal Forearm and Hand Deformity.

Scientific reports
2017

Pathophysiological analyses of periventricular nodular heterotopia using gyrencephalic mammals.

Human molecular genetics
2017

Achondroplasia: Development, pathogenesis, and therapy.

Developmental dynamics : an official publication of the American Association of Anatomists
2016

HDAC6 deficiency or inhibition blocks FGFR3 accumulation and improves bone growth in a model of achondroplasia.

Human molecular genetics
2016

Post-mortem cytogenomic investigations in patients with congenital malformations.

Experimental and molecular pathology
2016

Thanatophoric dysplasia: A review.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
2016

Approach to the diagnosis of skeletal dysplasias: Experience at a center with limited resources.

Journal of clinical ultrasound : JCU
2016

Protein-losing enteropathy with intestinal lymphangiectasia in skeletal dysplasia with Lys650Met mutation.

American journal of medical genetics. Part A
2016

Non-invasive prenatal diagnosis (NIPD) for single gene disorders: cost analysis of NIPD and invasive testing pathways.

Prenatal diagnosis
2016

Identification of a novel insertion mutation in FGFR3 that causes thanatophoric dysplasia type 1.

American journal of medical genetics. Part A
2016

A Case of Thanatophoric Dysplasia Type I with Fetal Hydrops in the First Trimester.

Case reports in obstetrics and gynecology
2016

A THANATOPHORIC DYSPLASIA TYPE I CASE WITH A FGFR3 P.R248C MUTATION AND SURVIVAL BEYOND THE NEONATAL PERIOD.

Genetic counseling (Geneva, Switzerland)
2016

Prenatal diagnosis of single gene disorders using amniotic fluid as the starting material for PCR.

The Analyst
2015

Three-dimensional and four-dimensional HDlive-rendered images of thanatophoric dysplasia.

Journal of medical ultrasonics (2001)
2015

Endoplasmic reticulum stress-mediated apoptosis contributes to a skeletal dysplasia resembling platyspondylic lethal skeletal dysplasia, Torrance type, in a novel Col2a1 mutant mouse line.

Biochemical and biophysical research communications
2016

Crystal Vue technique for imaging fetal spine and ribs.

Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
2015

Pathophysiological analyses of cortical malformation using gyrencephalic mammals.

Scientific reports
2015

[Cloverleaf skull and bilateral facial clefts].

Revista chilena de pediatria
2015

Perinatal Diagnostic Approach to Fetal Skeletal Dysplasias: Six Years Experience of a Tertiary Center.

Fetal and pediatric pathology
2015

Characterization of membrane protein interactions in plasma membrane derived vesicles with quantitative imaging Förster resonance energy transfer.

Accounts of chemical research
2016

Prediction of lethal pulmonary hypoplasia by means fetal lung volume in skeletal dysplasias: a three-dimensional ultrasound assessment.

The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2015

Thanatophoric dysplasia type 1 with cloverleaf skull in a dichorionic twin.

Genetic counseling (Geneva, Switzerland)
2015

A case of thanatophoric dysplasia type 2: a novel mutation.

Journal of clinical research in pediatric endocrinology
2015

Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach.

Prenatal diagnosis
2015

Increased first-trimester nuchal translucency associated with thanatophoric dysplasia type 1.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
2014

FGFR3 mutation frequency in 324 cases from the International Skeletal Dysplasia Registry.

Molecular genetics &amp; genomic medicine
2015

Effect of thanatophoric dysplasia type I mutations on FGFR3 dimerization.

Biophysical journal
2015

A new prescription for growth? Statins, cholesterol and cartilage homeostasis.

Osteoarthritis and cartilage
2014

Lethal short limb dwarfism: thanatophoric dysplasia- type I.

Journal of clinical and diagnostic research : JCDR
Ver todos os 224 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Displasia tanatofórica.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Displasia tanatofórica

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Type I Thanatophoric Dysplasia: Clinical Outcome in the Absence of Molecular Genetic Confirmation: A Case Report.
    Cureus· 2026· PMID 41869141mais citado
  2. The Clinical Utility of Whole-Exome Sequencing in the Prenatal Diagnosis of Fetal Skeletal Dysplasia.
    International journal of women's health· 2026· PMID 41868040mais citado
  3. [Clinical features and variant spectrum of FGFR3-related disorders].
    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics· 2025· PMID 41121704mais citado
  4. Thanatophoric Dysplasia Type 1 Treated with Vosoritide: A Case Report.
    Hormone research in paediatrics· 2025· PMID 41078071mais citado
  5. An immunohistochemical study of thanatophoric dysplasia type 1 after fetus autopsy examination.
    Congenital anomalies· 2025· PMID 39778871mais citado
  6. Thanatophoric dysplasia: A case report.
    Medwave· 2025· PMID 41183176recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2655(Orphanet)
  2. MONDO:0017042(MONDO)
  3. GARD:85(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)
  7. Q1787020(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Displasia tanatofórica
Compêndio · Raras BR

Displasia tanatofórica

ORPHA:2655 · MONDO:0017042
Prevalência
<1 / 1 000 000
Herança
Autosomal dominant, Not applicable
CID-10
Q77.1 · Nanismo tanatofórico
CID-11
Início
Antenatal, Neonatal
Prevalência
0.0 (Europe)
MedGen
UMLS
C0039743
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades